Acute reversal of allergen-induced airway hyperresponsiveness (AHR) by olodaterol is synergistically enhanced by tiotropium bromide Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011
Cardiopulmonary effects of inhaled ipratropium bromide and its combination with fenoterol in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 58s Year: 2002
Effect of patient age on response to nebulised salbutamol or ipratropium bromide Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management Year: 2012
A comparison of early bronchodilating responses of Salbutamol, Ipratropium bromide, and the combination of Ipratropium bromide-Salbutamol in stable patients with COPD or asthma Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002
Reversibility effects of ipratropium bromide and terbutalin sulphate in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 72s Year: 2001
Comparison of nebulized ipratropium bromide with salbutamol versus salbutamol alone in acute asthma exacerbation in children Source: Eur Respir J 2004; 24: Suppl. 48, 167s Year: 2004
How long should tiotropium bromide be suspended before methacholine challenge? Source: Eur Respir J 2006; 28: Suppl. 50, 218s Year: 2006
Influence of tiotropium bromide and formoterol on bronchial hyperresponsiveness in COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Assessments of protective effects of tiotropium bromide against methacholine- and neurokinin A-induced bronchoconstriction in patients with asthma Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011
Six months treatment with salmeterol or ipratropium bromide improves effort tolerance and reduces dyspnoea but does not have any effect on lung function in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 108s Year: 2002
Airway tone during exercise in healthy subjects: effects of salbutamol and ipratropium bromide Source: Eur Respir J 2003; 22: Suppl. 45, 89s Year: 2003
Pulmonary function and bronchodilator response to albuterol, ipratropium bromide and association of albuterol and ipratropium bromide in children with cystic fibrosis (CF) Source: Eur Respir J 2003; 22: Suppl. 45, 229s Year: 2003
Changes in the lung metabolic functions by inhalation of ipratropium bromide Source: International Congress 2019 – Exploring the lungs in various pathophysiological conditions Year: 2019
The impact of tiotropium for exercise induced bronchoconstriction Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017
Long-acting anticholinergic, aclidinium bromide (AB) significantly attenuates airway inflammation and hyper-responsiveness in an AF -induced murine model of asthma Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009
Comparative study of the effects of tiotropium bromide and budesonide on allergen-induced airway remodeling Source: Eur Respir J 2006; 28: Suppl. 50, 434s Year: 2006
Protection by formoterol and salmeterol on bronchoconstriction provoked by methacholine and AMP in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 307s Year: 2002
Influence of higher than conventional doses of salbutamol or ipratropium bromide on bronchodilation induced by a regular treatment with tiotropium in patients suffering from stable COPD Source: Eur Respir J 2007; 30: Suppl. 51, 356s Year: 2007
NVA237 has similar efficacy as tiotropium bromide against methacholine-induced bronchoconstriction and less systemic effect on cardiovascular variables in an anaesthetized rabbit model Source: Eur Respir J 2006; 28: Suppl. 50, 436s Year: 2006
Evaluation of bronchodilator response to single dose tiotropium bromide Source: Eur Respir J 2004; 24: Suppl. 48, 504s Year: 2004